The Autotaxin/Lysophosphatidic acid (ATX/LPA) pathway mediates inflammation and fibrosis and is upregulated in numerous fibrotic conditions (e.g., idiopathic pulmonary fibrosis, scleroderma and renal interstitial fibrosis) [90]. This evidence concerns the gene ENPP2 and pulmonary fibrosis.